ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6 | -68.4% | 2,298 | -56.2% | 0.00% | – |
Q2 2023 | $19 | +11.8% | 5,251 | 0.0% | 0.00% | – |
Q1 2023 | $17 | -64.6% | 5,251 | -48.1% | 0.00% | – |
Q4 2022 | $48 | -99.9% | 10,109 | 0.0% | 0.00% | – |
Q3 2022 | $57,000 | -46.2% | 10,109 | -32.4% | 0.00% | – |
Q2 2022 | $106,000 | +35.9% | 14,960 | +37.1% | 0.00% | – |
Q1 2022 | $78,000 | +2.6% | 10,908 | +26.7% | 0.00% | – |
Q4 2021 | $76,000 | – | 8,610 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
Atom Investors LP | 30,911 | $219,000 | 0.10% |
FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |